Literature DB >> 6404812

Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.

T Skogh, O Stendahl.   

Abstract

The effect of serum complement upon the blood clearance rate and tissue distribution of intravenously injected small immune complexes formed between 125-labelled dinitrophenyl (DNP)-conjugated human serum albumin and rabbit IgG-anti-DNP antibodies was studied in mice. Immune complexes formed in the absence of complement (i.e. in phosphate-buffered saline or in the presence of complement-depleted serum from mice treated with cobra venom factor) were cleared from the blood at a higher rate than was the antigen injected alone. In contrast, immune complexes formed in the presence of fresh normal mouse serum were cleared from the blood at the same rate as was the native antigen. Immune complexes formed in the presence of complement were eliminated mainly by the liver. The complexes formed in the absence of complement also became located to the liver to approximately the same extent, but an even larger proportion of these immune complexes was deposited outside the reticuloendothelial system. It is concluded that serum complement may inhibit IgG-mediated clearance of antigen, probably by increasing the solubility of the complexes, thereby reducing the risk of deposition outside the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404812      PMCID: PMC1454113     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

3.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

4.  Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus.

Authors:  A J Sliwinski; N J Zvaifler
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

5.  Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits.

Authors:  W P Arend; M Mannik
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

6.  The in vivo behaviour of complement-coated red cells: studies in C6-deficient, C3-depleted and normal rabbits.

Authors:  D L Brown; P J Lachmann; J V Dacie
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

7.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

8.  Tissue distribution of intravenously injected dinitrophenylated human serum albumin. Effects of specific IgG and IgA antibodies.

Authors:  T Skogh
Journal:  Scand J Immunol       Date:  1982-12       Impact factor: 3.487

9.  Complement system studies in systemic lupus erythematosus (SLE)

Authors:  P Teisberg
Journal:  Acta Med Scand       Date:  1975 Jan-Feb

10.  In vitro adherence of soluble immune complexes to macrophages.

Authors:  W P Arend; M Mannik
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  9 in total

1.  Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.

Authors:  D N Hogben; M E Devey
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

2.  Complement depletion accelerates the clearance of immune complexes from the circulation of primates.

Authors:  F J Waxman; L A Hebert; J B Cornacoff; M E VanAman; W L Smead; E H Kraut; D J Birmingham; J M Taguiam
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

3.  Hepatitis C Virus-related Mixed Cryoglobulinemia: Pathogenesis, Clinica Manifestations, and New Therapies.

Authors:  Neal J Schamberg; Gerond V Lake-Bakaar
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-09

4.  Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity.

Authors:  Jesper Karlsson; Jonas Wetterö; Maria Weiner; Johan Rönnelid; Rafael Fernandez-Botran; Christopher Sjöwall
Journal:  Arthritis Res Ther       Date:  2022-06-11       Impact factor: 5.606

5.  Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase.

Authors:  Chieko Yamamoto; Daisuke Tsuru; Naoko Oda-Ueda; Motonori Ohno; Shosaku Hattori; Sung-Teh Kim
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

6.  Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; N Dozio; E R Arquilla; B McDougall; C J De Vos; R von Frenckell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

7.  Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity.

Authors:  Klara Martinsson; Thomas Skogh; Seyed Ali Mousavi; Trond Berg; Jan-Ingvar Jönsson; Per Hultman
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

8.  Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.

Authors:  Christopher Sjöwall; Anders A Bengtsson; Gunnar Sturfelt; Thomas Skogh
Journal:  Arthritis Res Ther       Date:  2003-12-05       Impact factor: 5.156

Review 9.  The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus.

Authors:  Helena Enocsson; Jesper Karlsson; Hai-Yun Li; Yi Wu; Irving Kushner; Jonas Wetterö; Christopher Sjöwall
Journal:  J Clin Med       Date:  2021-12-13       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.